Erschienen in:
01.12.2014 | Meeting Report
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
verfasst von:
Rodolfo Montironi, Elizabeth H. Hammond, Daniel W. Lin, John L. Gore, John R. Srigley, Hema Samaratunga, Lars Egevad, Mark A. Rubin, John Nacey, Laurence Klotz, Howard Sandler, Anthony L. Zietman, Stuart Holden, Peter A. Humphrey, Andrew J. Evans, Brett Delahunt, Jesse K. McKenney, Daniel Berney, Thomas M. Wheeler, Arul Chinnaiyan, Lawrence True, Beatrice Knudsen, Jonathan I. Epstein, Mahul B. Amin
Erschienen in:
Virchows Archiv
|
Ausgabe 6/2014
Einloggen, um Zugang zu erhalten
Abstract
Active surveillance (AS) is an important management option for men with low-risk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts matures. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and consistently reported by surgical pathologists. This report highlights the importance of accurate pathology reporting as a critical component of these protocols.